loading
전일 마감가:
$1.535
열려 있는:
$1.54
하루 거래량:
41,106
Relative Volume:
0.15
시가총액:
$66.05M
수익:
$51.13M
순이익/손실:
$-93.80M
주가수익비율:
-0.6906
EPS:
-2.23
순현금흐름:
$-129.10M
1주 성능:
+1.32%
1개월 성능:
+2.67%
6개월 성능:
+30.51%
1년 성능:
-46.71%
1일 변동 폭
Value
$1.53
$1.56
1주일 범위
Value
$1.48
$1.56
52주 변동 폭
Value
$0.89
$4.0695

Repare Therapeutics Inc Stock (RPTX) Company Profile

Name
명칭
Repare Therapeutics Inc
Name
전화
(857) 412-7018
Name
주소
7171 FREDERICK BANTING, SAINT-LAURENT, QC
Name
직원
129
Name
트위터
@reparerx
Name
다음 수익 날짜
2025-08-08
Name
최신 SEC 제출 서류
Name
RPTX's Discussions on Twitter

RPTX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
RPTX
Repare Therapeutics Inc
1.54 65.84M 51.13M -93.80M -129.10M -2.23
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
374.46 93.98B 11.42B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
435.00 57.53B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
545.94 59.67B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
638.90 40.50B 3.05B 1.28B -614.78M 19.58
Biotechnology icon
ONC
Beone Medicines Ltd Adr
289.75 34.26B 3.81B -644.79M -669.77M -6.24

Repare Therapeutics Inc Stock (RPTX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2023-06-09 업그레이드 Stifel Hold → Buy
2023-02-03 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2023-01-06 개시 CapitalOne Overweight
2022-04-12 다운그레이드 Stifel Buy → Hold
2022-03-17 재개 Goldman Buy
2021-09-23 개시 Stifel Buy
2021-09-13 개시 H.C. Wainwright Buy
2021-06-28 개시 Guggenheim Buy
2021-03-01 개시 Berenberg Buy
2020-10-28 개시 Northland Capital Outperform
2020-07-14 개시 Cowen Outperform
2020-07-14 개시 Goldman Neutral
2020-07-14 개시 Morgan Stanley Overweight
2020-07-14 개시 Piper Sandler Overweight
모두보기

Repare Therapeutics Inc 주식(RPTX)의 최신 뉴스

pulisher
Aug 11, 2025

Using portfolio simulators with Repare Therapeutics Inc. includedSafe Investment Ideas with Growth Upside - Newser

Aug 11, 2025
pulisher
Aug 11, 2025

Repare Therapeutics (NASDAQ:RPTX) Posts Earnings Results - MarketBeat

Aug 11, 2025
pulisher
Aug 11, 2025

Is Repare Therapeutics Inc. forming a reversal patternFree Market Surge Signal for Swing Traders - Newser

Aug 11, 2025
pulisher
Aug 11, 2025

Backtesting results for Repare Therapeutics Inc. trading strategiesPattern Recognition Based Market Move Prediction - Newser

Aug 11, 2025
pulisher
Aug 10, 2025

Is Repare Therapeutics Inc. still worth holding after the dipFree AI-Powered Trade Planning with Indicators - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

Is Repare Therapeutics Inc. Stock a Good Fit for Conservative InvestorsSafe Momentum Strategy With Trend Analysis - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

Repare Therapeutics Q2 2025 Earnings: EPS Beats Estimates, Revenue Surpasses Expectations - AInvest

Aug 10, 2025
pulisher
Aug 10, 2025

Will Repare Therapeutics Inc. benefit from macro trendsDay Trading Plan with Entry Risk Management - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

Analyzing recovery setups for Repare Therapeutics Inc. investorsFree Smart Trend Trading with Weekly Signals - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

Repare Therapeutics Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance

Aug 10, 2025
pulisher
Aug 10, 2025

Repare Therapeutics Reports Q2 2025 Results and Strategic Moves - TipRanks

Aug 10, 2025
pulisher
Aug 10, 2025

Repare Therapeutics (NASDAQ:RPTX) Raised to "Hold" at Wall Street Zen - MarketBeat

Aug 10, 2025
pulisher
Aug 09, 2025

Repare Therapeutics Reports Q2 Earnings: Strategic Moves and Upcoming Data Releases - AInvest

Aug 09, 2025
pulisher
Aug 09, 2025

Repare 2025 Q2 Earnings Strong Improvement as Net Loss Narrows 51.8% - AInvest

Aug 09, 2025
pulisher
Aug 08, 2025

Repare Therapeutics Cuts Losses And Snags New Licensing Deals - Finimize

Aug 08, 2025
pulisher
Aug 08, 2025

Repare Therapeutics Narrows Losses And Seeks New Paths Forward - Finimize

Aug 08, 2025
pulisher
Aug 08, 2025

Repare (RPTX) Q2 Loss Narrows 52% - AOL.com

Aug 08, 2025
pulisher
Aug 08, 2025

Repare Therapeutics' Strategic Shift and Milestone-Driven Outlook - AInvest

Aug 08, 2025
pulisher
Aug 08, 2025

Repare Therapeutics Announces Licensing Deal and Strategic Updates - TipRanks

Aug 08, 2025
pulisher
Aug 08, 2025

Repare Therapeutics Inc. (RPTX) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance

Aug 08, 2025
pulisher
Aug 08, 2025

Repare Therapeutics reports Q2 EPS (39c) vs. (82c) last year - TipRanks

Aug 08, 2025
pulisher
Aug 08, 2025

Repare Therapeutics Inc. SEC 10-Q Report - TradingView

Aug 08, 2025
pulisher
Aug 08, 2025

Repare Therapeutics Q2 net loss narrows to $16.7 mln - MarketScreener

Aug 08, 2025
pulisher
Aug 08, 2025

Repare Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results | RPTX Stock News - GuruFocus

Aug 08, 2025
pulisher
Aug 08, 2025

Repare Therapeutics reports Q2 2025 revenue $109.5 mln, cash & marketable securities. - AInvest

Aug 08, 2025
pulisher
Aug 08, 2025

Repare Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results - The Globe and Mail

Aug 08, 2025
pulisher
Aug 08, 2025

Predicting Repare Therapeutics Inc. trend using moving averagesChart Scanner for Swing Trade Timing - Newser

Aug 08, 2025
pulisher
Aug 06, 2025

Why Repare Therapeutics Inc. stock attracts strong analyst attentionFree Daily Profit Focused Stock Screener - Newser

Aug 06, 2025
pulisher
Aug 05, 2025

Can Repare Therapeutics Inc. hit a new high this monthFree Low Risk Swing Trade Opportunity List - Newser

Aug 05, 2025
pulisher
Aug 03, 2025

Quantitative breakdown of Repare Therapeutics Inc. recent movePredicted Market Direction Based on Momentum - Newser

Aug 03, 2025
pulisher
Aug 03, 2025

What makes Repare Therapeutics Inc. stock price move sharplyUnlock market-leading stock analysis - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Should I hold or sell Repare Therapeutics Inc. stock in 2025Maximize gains with proven stock analysis - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Repare Therapeutics Inc. Stock Analysis and ForecastAchieve rapid wealth accumulation with smart picks - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How volatile is Repare Therapeutics Inc. stock compared to the marketMaximize portfolio value with smart investment plans - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

When is Repare Therapeutics Inc. stock expected to show significant growthAmplify your gains with low-risk picks - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Does Repare Therapeutics Inc. stock perform well during market downturnsMaximize returns with data-driven strategies - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Is Repare Therapeutics Inc. a growth stock or a value stockUnlock your portfolio’s hidden potential - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How many analysts rate Repare Therapeutics Inc. as a “Buy”Capitalize on momentum stocks before they peak - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How does Repare Therapeutics Inc. compare to its industry peersCapitalize on fast-moving trading opportunities - Jammu Links News

Aug 03, 2025
pulisher
Aug 02, 2025

Is Repare Therapeutics Inc. a good long term investmentUnlock powerful market insights for success - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

How does Repare Therapeutics Inc. generate profit in a changing economyGet ahead with breakthrough trading ideas - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

What are Repare Therapeutics Inc. company’s key revenue driversBuild wealth steadily with proven strategies - Jammu Links News

Aug 02, 2025

Repare Therapeutics Inc (RPTX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$79.19
price up icon 1.02%
$36.19
price down icon 3.70%
$28.25
price down icon 1.43%
$112.89
price up icon 3.05%
$109.26
price down icon 2.15%
biotechnology ONC
$289.75
price up icon 0.54%
자본화:     |  볼륨(24시간):